Thursday, October 8, 2026 | UTC
About | Contact | API Status
Sign In Subscribe
Live
AAPL $336.67 +0.91%
MSFT $529.76 +0.09%
GOOGL $350.50 +0.81%
AMZN $259.92 +1.42%
TSLA $377.81 -0.75%
META $721.31 -2.38%
NVDA $237.47 -0.74%
JPM $329.58 -0.51%
BTC $36.88 -2.54%
ETH $24.50 -4.52%
Latest Signing ceremony for contribution agreements between WHO and France Oct 17, 2024
AAPL
$336.67
▲ 0.91%
MSFT
$529.76
▲ 0.09%
GOOGL
$350.50
▲ 0.81%
AMZN
$259.92
▲ 1.42%
TSLA
$377.81
▼ 0.75%
META
$721.31
▼ 2.38%
NVDA
$237.47
▼ 0.74%
JPM
$329.58
▼ 0.51%

Top Stories

Markets →
All Markets Technology Economy Science Health Sports Entertainment Politics
Bloomberg Markets
Diversify Outside of 'AI Only Play' Says Mamadou-Abou Sarr
Wall Street traders drove stocks down from the brink of all-time highs as a renewed slide in SpaceX overshadowed optimism about progress in peace talks between the US and Iran. Mamadou-Abou Sarr, President & Co-Founder of V-Square Quantitative Management discusses the markets and how he is encouraging diversified investing. (Source: Bloomberg)
business  Jun 22, 2026
Variety
‘Let Us Be’ Director Viviane D’Avilla Talks About Shining a Light on Intersex Rights in the U.S.: ‘Their Rights Are Being Taken Away’
Over a decade ago, Brazilian photographer and filmmaker Viviane D’Avilla traveled to India looking to develop a photography project based on the country’s culture and spirituality. There, she met members of the Indian Hijra community, a legally recognized third gender encompassing those who are transgender, intersex or eunuchs. That meeting would completely change D’Avilla’s project […]
entertainment  Jun 22, 2026
Bloomberg Markets
AbbVie's Deal with Apogee; Regenxbio Moves on Gene Therapy Drug | Stock Movers
On this episode of Stock Movers with Nathan Hager: - Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Financial Times report. - Regenxbio (RGNX) shares are moving on news Regenxbio aligned with the FDA on next steps for a potential accelerated approval of Navsunli, a gene therapy for Mucopolysaccharidosis II, with the FDA confirming the company doesn’t need to co
business  Jun 22, 2026
The Guardian Politics
Keir Starmer resigns: what now? – podcast
An emotional Keir Starmer announced his resignation as prime minister and Labour leader on Monday morning, less than two years after he won a huge majority at the general election. The question now is who will replace him: will Andy Burnham sweep into No 10 uncontested? And can he make a difference where Starmer failed? Continue reading...
politics  Jun 22, 2026

Stay ahead of the markets.

Get free access to breaking news, stock data, and market analysis.

Subscribe Free